Evans John M.'s Form 4 filing
Beam Therapeutics Inc. (BEAM) · filed Apr 1, 2024
- Accession no.
- 0000950170-24-039319
- Filed
- Apr 1, 2024
- Trade date
- Mar 28-31, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.03M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Evans John M.CIK 0001786304 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 28, 2024 | Common Stock | SSaleDisposed | −60,000 | $33.86 | −$2,031,600 | 998,262 | Direct | |
| Mar 31, 2024 | Common Stock | AGrant or awardAcquired | +77,500 | $0.00 | $0 | 1,076,445 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.